Florentina Dumitrescu

Dr. Florentina Dumitrescu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2022 in Medicina
Verified
Journal Article
Open access
PDF file
SCSIMONA CLAUDIA CAMBREA
SIMONA CLAUDIA CAMBREA
EMEugenia-Andreea Marcu
Eugenia-Andreea Marcu
ECElena Cucli
Elena Cucli
DBDiana Badiu
Diana Badiu
RPRoxana Penciu
Roxana Penciu
FDFlorentina Dumitrescu
Florentina Dumitrescu
Background and Objectives: The occurrence of human immunodeficiency virus (HIV) infection in children in Romania has been reported since 1989. This retrospective study was aimed at assessing clinical and biological risk factors for mother-to-child transmission (MTCT) of HIV in two HIV-acquired immune deficiency syndrome (AIDS) Regional Centers (RCs), Constanta and Craiova in Romania. Materials and Methods: During the study period (2008–2019), 408 HIV-positive pregnant women, 244 from Constanta RC and 164 from Craiova RC who attended antenatal visits, were included. All HIV-positive pregnant women were under combined antiretroviral therapy (cART) during pregnancy and childbirth, being followedup with their infants up to 18 months after delivery. We investigated the clinical as well as biological risk factorsassociated with increased MTCT of HIV. Results: Comparing different variables of HIV-positive pregnant women from the two HIV-AIDS CRs, we find that there are significant differences between the mean value of hemoglobin, CD4 level, environmental area, marital and amniotic membranes status, and HIV patient stage in the last trimester of pregnancy (p < 0.05), but without any differences in mother’s mean age, education level, type of delivery, breastfeeding, the duration of cART administration, HIV viral load, and survival rate. Conclusions: In 408 HIV-positive pregnant women followed up at two HIV-AIDS RCs in Romania, the most important clinical and biological risk factors associated with increased MTCT of HIV are represented by anemia, CD4 level, and HIV patient stage.

6 February 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
EMEugenia-Andreea Marcu
Eugenia-Andreea Marcu
SDSorin-Nicolae Dinescu
Sorin-Nicolae Dinescu
Vlad PadureanuVlad Padureanu
Vlad Padureanu
FDFlorentina Dumitrescu
Florentina Dumitrescu
RDRadu Diaconu
Radu Diaconu
Background and objectives: HIV infection in pregnant women can be responsible for a number of consequences during pregnancy, such as: maternal anaemia, miscarriage, low birth weight, and preterm birth. The objectives of this study were to determine the maternal–foetal transmission rate of HIV among pregnant women living with HIV from Craiova Regional Centre in order to assess the risk factors for mother-to-child transmission of HIV and to identify the characteristics of newborns perinatally exposed to HIV. Materials and methods: A retrospective study was conducted between 1 January 2011 and 31 December 2020, including children born to HIV-positive mothers. Results: The studied group included 138 newborns and was divided into two subgroups: group A, which included 10 HIV-infected infants; and group B, which included 128 uninfected infants. The mother-to-child transmission rate was 3.5% for women to whom all prophylaxis standards were applied. We found a statistically significant correlation between the level of maternal HIV viremia and perinatal HIV transmission (p = 0.01). Preterm birth and low birth weight were associated with perinatal transmission of the infection. Conclusions: Perinatal transmission of HIV infection during our study was associated with inconsistent application of screening for HIV infection among pregnant women, lack of antiretroviral therapy, poor adherence to treatment, and detectable HIV viral load during pregnancy.

22 June 2022 in Life
Verified
Journal Article
Open access
PDF file
AKADINA MARIA KAMAL
ADINA MARIA KAMAL
FDFlorentina Dumitrescu
Florentina Dumitrescu
AMAdrian Mita
Adrian Mita
DSDenisa Sabiescu
Denisa Sabiescu
DADragos Ovidiu Alexandru
Dragos Ovidiu Alexandru
CKConstantin K. Kamal
Constantin K. Kamal
Background: The coronavirus disease 2019 pandemic (COVID-19) is the most important global health crisis to date. In this study, we performed an analysis to find the association between liver damage, FIB-4 score and the severity of COVID-19 disease. Methods: We included a total of 580 patients that tested positive for SARS-CoV-2 infection and were hospitalized. No patient included had any known history of liver disease. Liver function tests were performed, and FIB-4 score was calculated in order to assess their involvement in the disease progression. Results: More than half of the patients had elevated liver function tests. Age, high body mass index, associated heart disease and diabetes were associated with poor outcome. Corticosteroids, antibiotics, and anticoagulants strongly correlated with liver injuries. Liver impairment and injury, as well as a FIB-4 score higher than 3.5, also correlated with higher degrees of disease severity. Conclusion: Liver injury and elevated FIB-4 score were associated with poor clinical outcome and disease severity, as well as being a valuable tool to predict COVID-19-related mortality.

16 June 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
GMGiorgiana Nicoleta Milcu
Giorgiana Nicoleta Milcu
GDGheorghe Iulian DIACONESCU
Gheorghe Iulian DIACONESCU
FDFlorentina Dumitrescu
Florentina Dumitrescu
Anca Oana DoceaAnca Oana Docea
Anca Oana Docea
RMRadu Mitrut
Radu Mitrut
PMPaul Mitrut
Paul Mitrut
The study aimed to determine liver fibrosis in human immunodeficiency virus (HIV) positive individuals using transient elastography (FibroScan®), Fibrosis-4 (FIB-4) score, and aspartate aminotransferase (AST) to Platelet Ratio Index (APRI) in the HIV Department from Infectious Diseases Hospital “Victor Babeș” Craiova, Romania. Of the analyzed HIV-positive subjects (n = 161), 93 (57.76%) had HIV mono-infection, and 68 (42.24%) had Hepatitis B Virus (HBV) co-infection. The prevalence of advanced liver fibrosis was higher (F2: 11.76% and F3: 13.24%, F4: 4.41%) in the HIV-HBV co-infected group compared to the HIV mono-infected group. The univariate and multivariate analysis identified HBV co-infection (OR = 5.73) male sex (OR = 5.34), serum aspartate amino-transferase levels (Pearson’s rho = 0.273), low platelet count (Pearson’s rho = −0.149) and erythrocyte sedimentation rate (OR = 1.030) as risk factors for the presence of liver fibrosis. Body mass index (OR = 1.08), serum lipid levels (OR = 0.96), viral load at diagnosis (OR = 1.00005), and low CD4+ cell count (OR = 0.977) were also correlated with liver fibrosis. The FIB-4 and APRI scores were strongly correlated with each other. In conclusion, HBV co-infection seems to be a determinant factor for liver fibrosis development in people living with HIV, together with other risk factors.

23 May 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
FDFlorentina Dumitrescu
Florentina Dumitrescu
EGEugen Florin Georgescu
Eugen Florin Georgescu
LGLucian Giubelan
Lucian Giubelan
Vlad PadureanuVlad Padureanu
Vlad Padureanu
ASAndreea Cristina Stoian
Andreea Cristina Stoian
DMDaniela Marinescu
Daniela Marinescu
Bacillus anthracis is the causative agent of anthrax, primarily a disease of herbivorous animals, which can be accidentally transmitted to humans. Three cases of cutaneous human anthrax were recorded in August 2020 in Dolj county, Romania. These cases included livestock farmers (husband and wife, as well as a man from their entourage). The women presented malignant edema, which required surgery for compartment syndrome; and the men presented the common form of cutaneous anthrax. According to the laboratory investigation, two cases complied with the criteria in the case definition. All cases were successfully treated with antibiotics and the women received reconstructive plastic surgery of the skin defects, restoring normal hand function. The contact with sick animals was ruled out by the health authorities concluding that it was the contamination of pre-existing skin lesions with B. anthracis spores from the soil, the anthracogenic area.

14 October 2021 in Medicina
Verified
Journal Article
Open access
PDF file
LGLucian Giubelan
Lucian Giubelan
LDLivia Dragonu
Livia Dragonu
Vlad PadureanuVlad Padureanu
Vlad Padureanu
ANAlexandru Neacșu
Alexandru Neacșu
MMMirela Mănescu
Mirela Mănescu
FDFlorentina Dumitrescu
Florentina Dumitrescu
Lemierre’s syndrome is, presently, a very rare condition, but a life-threatening one. The syndrome was first described in 1936 by Andre Lemierre and comprises an oropharyngeal infection (most commonly associated with anaerobic bacteria Fusobacterium necrophorum), internal jugular vein thrombophlebitis and, possibly, secondary septic metastasis (common sites are lungs or brain). We describe such a rare case diagnosed at our Infectious Diseases Department in September 2019.